We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 0.42% | 35.65 | 35.40 | 35.90 | 36.50 | 34.05 | 36.50 | 425,707 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.25 | 106.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/1/2024 18:17 | Funny as I was pretty sure many of the early positive reviews were shareholders. Actual verified buyers tell a very different story. How it's selling so well, is evidence of the demand, rather than effectiveness. From my experience not even a placebo effect. | waterloo01 | |
08/1/2024 18:15 | If the Eroxon reviews are "fake", why are 'regulars' here showing so much concern? | glavey | |
08/1/2024 18:06 | "The page they didnt want you to see" You could be right there, it's the one 'filter' setting that doesn't seem to vary the default display. Wonder why Boots don't want 'you' to see it? | glavey | |
08/1/2024 17:52 | "Glavey also posting fake info" Hardly "fake info" when it's there on a recognised external website (www.boots.com) for all to see. Some need to 'make things up'. I mearly reference that which is visible to anyone where the source would seem credible and openly published. | glavey | |
08/1/2024 17:08 | As a FUM holder I'm delighted with today's rise. Eroxon is not for me. It is clearly for clinical erectile dysfunction rather than 'recreational' use. My hope is that Eroxon will be a Heineken product refreshing the parts that other treatments like Viagra can't reach. If it is commercially successful then FUM will be gobbled up by a larger player with hopefully very deep pockets. | kinwah | |
08/1/2024 16:17 | Current average price target is around 145p I am expecting an upgrade to over 200p as USA launch date is announced | j777j | |
08/1/2024 15:57 | So obvious the reviews are fake they all keep refer to the blue pill.They also repeat the same words The trolls employed to post those fake reviews were rather dimwitted. EROXON is soon to be launched into the USA by Haleon one of the worlds largest consumer health cos Get rich or die trying | j777j | |
08/1/2024 15:23 | Exactly.....and Boots subsequently awarded Eroxon "best new product of the year" (or similar words) despite the dodgy reviews. They are well aware. Sales numbers is what I want to see, that's what it all boils down to. Oh and an update on the US. | broomrigg | |
08/1/2024 14:03 | KPE - there has been a concerted effort to undermine Eroxon with dodgy reviews. In a video conference that FUM did, it was said that Boots were aware of dodgy reviews being placed. But it appears they aren't doing anything about it. I have contacted Boots about the postings but didn't have the decency to respond. I also did try and write a review, slagging off Boots and their review set-up but as you can imagine they didn't allow the review to appear. Which sums up Boots | keifer derrin | |
08/1/2024 12:43 | The purchased reviews aren't great. A lot of 1stars..... They all say the blue pill is best. | kpe | |
08/1/2024 11:20 | Yes amazing.How long will Fum be able to remain independent?It has a highly scaleable global brand in the making | j777j | |
08/1/2024 10:32 | Selling faster than Viagra, Cialis, Boots own ED products, Durex etc etc etc | broomrigg | |
08/1/2024 09:55 | Crikey, something's worrying Glavey - four posts in a row!- and MDI. I wonder what it is? Hahahahahahahahaha! | petroc | |
08/1/2024 09:42 | You are wrong againAll cleared for USA launchHaleon one of the largest consumer healthcare brands on the planet | j777j | |
08/1/2024 09:31 | See that FDA letter to Futura dated June 9 2023 which the FDA have published? Its all under Haleon control now. Dear Ken James: Page 3 ‘Please be advised that FDA's decision to grant this De Novo request does not mean that FDA has made a determination that your device complies with other requirements of the FD&C Act or any Federal statutes and regulations administered by other Federal agencies’ | mdi | |
08/1/2024 09:19 | Like the attendance figures at the 200p party? | glavey | |
08/1/2024 08:53 | "have a mate who tried it and is over the moon with and swears by it" There's a guy, works down the chip shop, swears he's Elvis... Erexon: 308 out of 395 (79%) reviewers recommend this product Eroxon: 322 out of 428 (75.23%) reviewers don't recommend this product "Share price is telling you something" Sure is... "Also the overhang from the last 6 months has cleared." Anything else you'd like to 'make up' whilst you are at it? | glavey |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions